Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
78.95B | 94.23B | 142.42B | 96.55B | 64.23B | Gross Profit |
32.47B | 33.57B | 28.71B | 30.96B | 23.27B | EBIT |
15.49B | 10.83B | 11.19B | 17.09B | 11.76B | EBITDA |
22.74B | 19.39B | 20.11B | 16.40B | 14.95B | Net Income Common Stockholders |
7.02B | 3.44B | 5.22B | 3.19B | 3.62B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
10.92B | 11.33B | 24.79B | 11.02B | 6.37B | Total Assets |
187.14B | 195.22B | 219.62B | 206.94B | 163.45B | Total Debt |
70.35B | 73.56B | 87.91B | 70.92B | 58.66B | Net Debt |
62.30B | 66.76B | 76.86B | 62.06B | 52.76B | Total Liabilities |
137.97B | 150.12B | 177.54B | 164.60B | 121.10B | Stockholders Equity |
33.73B | 31.75B | 28.66B | 29.65B | 28.32B |
Cash Flow | Free Cash Flow | |||
4.29B | 1.85B | -4.57B | -2.13B | 1.96B | Operating Cash Flow |
13.22B | 14.62B | 8.67B | 10.07B | 11.51B | Investing Cash Flow |
-4.11B | -10.61B | -13.63B | -10.88B | -10.12B | Financing Cash Flow |
-7.99B | -8.36B | 7.37B | 3.78B | -3.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $6.00B | 4.14 | 26.38% | 15.72% | -4.14% | 13.02% | |
79 Outperform | $6.38B | 12.43 | 9.22% | 4.93% | -7.02% | 17.33% | |
74 Outperform | $51.15B | 17.08 | 9.76% | 3.23% | -0.39% | 0.75% | |
69 Neutral | $91.47B | 11.84 | 25.04% | 2.79% | -8.80% | 61.27% | |
63 Neutral | $8.57B | 10.13 | 4.66% | 4.38% | 3.79% | -12.91% | |
55 Neutral | $8.69B | 6.67 | 29.79% | 5.68% | -3.22% | 141.11% | |
54 Neutral | $21.44B | 2,867.59 | 0.47% | 5.00% | 12.40% | -108.27% |